Cargando…

Prognosis Individualized: Survival predictions for WHO grade II and III gliomas with a machine learning-based web application

WHO grade II and III gliomas demonstrate diverse biological behaviors resulting in variable survival outcomes. In the context of glioma prognosis, machine learning (ML) approaches could facilitate the navigation through the maze of factors influencing survival, aiding clinicians in generating more p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karabacak, Mert, Jagtiani, Pemla, Carrasquilla, Alejandro, Germano, Isabelle M., Margetis, Konstantinos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10603035/ https://www.ncbi.nlm.nih.gov/pubmed/37884599 http://dx.doi.org/10.1038/s41746-023-00948-y

Ejemplares similares

Interpretable machine learning models to predict short-term postoperative outcomes following posterior cervical fusion
por: Karabacak, Mert, et al.
Publicado: (2023)

A Machine Learning-Based Online Prediction Tool for Predicting Short-Term Postoperative Outcomes Following Spinal Tumor Resections
por: Karabacak, Mert, et al.
Publicado: (2023)

Embracing Large Language Models for Medical Applications: Opportunities and Challenges
por: Karabacak, Mert, et al.
Publicado: (2023)

Technical Optimization of Decompressive Craniectomy for Possible Conversion to Hinge Craniotomy in Traumatic Brain Injury
por: Ahmed, Abdul-Kareem, et al.
Publicado: (2023)

Bevacizumab in recurrent WHO grades II–III glioma
por: Annakib, Soufyan, et al.
Publicado: (2023)

Basement-Membrane-Related Gene Signature Predicts Prognosis in WHO Grade II/III Gliomas
por: Zhang, Zhaogang, et al.
Publicado: (2022)

The Advent of Generative Language Models in Medical Education
por: Karabacak, Mert, et al.
Publicado: (2023)

Radiosurgery for high-grade glioma
por: Binello, Emanuela, et al.
Publicado: (2012)

Multiparametric MRI-based differentiation of WHO grade II/III glioma and WHO grade IV glioblastoma
por: Wiestler, Benedikt, et al.
Publicado: (2016)

T2 mapping of molecular subtypes of WHO grade II/III gliomas
por: Kern, Maike, et al.
Publicado: (2020)

Assessment of Computed Tomography Perfusion Research Landscape: A Topic Modeling Study
por: Ozkara, Burak B., et al.
Publicado: (2023)

Epidemiological trends, relative survival, and prognosis risk factors of WHO Grade III gliomas: A population‐based study
por: Fang, Jun‐Hao, et al.
Publicado: (2019)

A Model for Predicting Clinical Prognosis in Patients with WHO Grade 2 Glioma
por: Gao, Qi, et al.
Publicado: (2022)

Integrative analysis of TP73 profile prognostic significance in WHO grade II/III glioma
por: Chen, Yanming, et al.
Publicado: (2021)

Importance of evaluating health-related quality of life issues in survivors of WHO grade II or III gliomas
por: Dirven, Linda
Publicado: (2022)

MNG-03 PD-L1 EXPRESSION, PATIENT PROGNOSIS AND INITIAL WHO GRADE IN GRADE II/III MENINGIOMA
por: Kamamoto, Dai, et al.
Publicado: (2019)

SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II–III Diffuse Gliomas
por: Zhang, Yu-An, et al.
Publicado: (2016)

Treatment Recommendations for Adult Patients with Diffuse Gliomas of Grades II and III According to the New WHO Classification in 2016
por: SASAKI, Hikaru, et al.
Publicado: (2017)

Diffusion tensor image features predict IDH genotype in newly diagnosed WHO grade II/III gliomas
por: Eichinger, Paul, et al.
Publicado: (2017)

Neuro-oncology management during the COVID-19 pandemic with a focus on WHO grades III and IV gliomas
por: Bernhardt, Denise, et al.
Publicado: (2020)

Association of perioperative adverse events with subsequent therapy and overall survival in patients with WHO grade III and IV gliomas
por: Weber, Lorenz, et al.
Publicado: (2022)

Facing Contrast-Enhancing Gliomas: Perfusion MRI in Grade III and Grade IV Gliomas according to Tumor Area
por: Di Stefano, Anna Luisa, et al.
Publicado: (2014)

A 25-year retrospective, single center analysis of 343 WHO grade II/III glioma patients: implications for grading and temozolomide therapy
por: Steidl, Eike, et al.
Publicado: (2021)

Subtyping of gliomas of various WHO grades by the application of immunohistochemistry
por: Popova, Svetlana N, et al.
Publicado: (2014)

Immune-related genes with APA in microenvironment indicate risk stratification and clinical prognosis in grade II/III gliomas
por: Xu, Shengchao, et al.
Publicado: (2021)

Recursive partitioning analysis of prognostic factors in WHO grade III glioma patients treated with radiotherapy or radiotherapy plus chemotherapy
por: Park, Chul-Kee, et al.
Publicado: (2009)

The Korean Society for Neuro-Oncology (KSNO) Guideline for WHO Grade III Cerebral Gliomas in Adults: Version 2019.01
por: Kim, Young Zoon, et al.
Publicado: (2019)

Radiological differences between subtypes of WHO 2016 grade II–III gliomas: a systematic review and meta-analysis
por: van Lent, Djuno I, et al.
Publicado: (2020)

The Value of H2BC12 for Predicting Poor Survival Outcomes in Patients With WHO Grade II and III Gliomas
por: Zhou, Jie, et al.
Publicado: (2022)

Current therapeutic approaches to diffuse grade II and III gliomas
por: Picca, Alberto, et al.
Publicado: (2018)

Deep learning for prediction of isocitrate dehydrogenase mutation in gliomas: a critical approach, systematic review and meta-analysis of the diagnostic test performance using a Bayesian approach
por: Karabacak, Mert, et al.
Publicado: (2022)

Machine learning-based identification of lower grade glioma stemness subtypes discriminates patient prognosis and drug response
por: Zhou, Hongshu, et al.
Publicado: (2023)

A novel, effective machine learning-based RNA editing profile for predicting the prognosis of lower-grade gliomas
por: Wang, Boshen, et al.
Publicado: (2023)

Radiation Treatment for WHO Grade II and III Meningiomas
por: Walcott, Brian P., et al.
Publicado: (2013)

Mitotic and Proliferative Indices in WHO Grade III Meningioma
por: Daniela Maier, Andrea, et al.
Publicado: (2020)

Nrf2 Expressions Correlate with WHO Grades in Gliomas and Meningiomas
por: Tsai, Wen-Chiuan, et al.
Publicado: (2016)

The presence of TIM‐3 positive cells in WHO grade III and IV astrocytic gliomas correlates with isocitrate dehydrogenase mutation status
por: Sørensen, Mia D., et al.
Publicado: (2021)

Long-term impact of adult WHO grade II or III gliomas on health-related quality of life: A systematic review
por: Frances, Sé Maria, et al.
Publicado: (2021)

EVA1C Is a Potential Prognostic Biomarker and Correlated With Immune Infiltration Levels in WHO Grade II/III Glioma
por: Hu, Zhicheng, et al.
Publicado: (2021)

An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas
por: Zhang, Hongbo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0kbvfqlmcmh7ou353aah22fhrg